In hematological malignancies, especially in B cell tumors such as multiple myeloma [32], non-Hodgkin B-lymphoma, and B-CLL [12,33], HLA-G may exert anti-tumor activities through the direct inhibition of tumor cell proliferation. Here, HLA-G is linked to plasma cell myeloma.